Thomas C. Chesterman
Director of Finance/CFO bei SENESTECH, INC.
Vermögen: 1 $ am 31.03.2024
Profil
Thomas C.
Chesterman is currently the CFO, Secretary, Treasurer & Executive VP at SenesTech, Inc. He previously held positions as the Chief Financial Officer & Vice President at Bio-Rad Laboratories, Inc. from 1996 to 2002, Treasurer & Vice President-Finance at General Communication, Inc. from 2013 to 2015, Chief Financial Officer & Senior Vice President at Aradigm Corp.
from 2002 to 2007, CFO, Senior VP & Head-Investor Relations at Bionovo, Inc. from 2007 to 2012, and Chief Financial Officer & Vice President-Strategy at Europolitan Holdings AB from 1993 to 1996.
Mr. Chesterman obtained his undergraduate degree from Harvard University in 1982 and his MBA from the University of California, Davis in 1984.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENESTECH, INC.
0,00% | 28.07.2023 | 2 ( 0,00% ) | 1 $ | 31.03.2024 |
Aktive Positionen von Thomas C. Chesterman
| Unternehmen | Position | Beginn |
|---|---|---|
| SENESTECH, INC. | Director of Finance/CFO | 01.09.2015 |
Ehemalige bekannte Positionen von Thomas C. Chesterman
| Unternehmen | Position | Ende |
|---|---|---|
General Communication, Inc.
 General Communication, Inc. Specialty TelecommunicationsCommunications General Communication, Inc. is a holding company. It provides wireless telephone services, data services, Internet access, video services and local and long-distance voice services, to residential and business customers across the state under its GCI brand. It operates through the Wireless and Wireline segments. The Wireless segment provides wholesale wireless services to wireless carriers. The Wireline segment offers services and products to the following three major customer groups: Consumer, Business Services and Managed Broadband. The company was founded by Robert M. Walp and Ronald A. Duncan in 1979 and is headquartered in Anchorage, AK. | Investor Relations Contact | 01.01.2015 |
| BIONOVO INC. | Director of Finance/CFO | 03.01.2012 |
| ARADIGM CORPORATION | Director of Finance/CFO | 20.06.2007 |
| BIO-RAD LABORATORIES, INC. | Director of Finance/CFO | 01.01.2002 |
| Europolitan Holdings AB | Director of Finance/CFO | 01.01.1996 |
Ausbildung von Thomas C. Chesterman
| Harvard University | Undergraduate Degree |
| University of California, Davis | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| SENESTECH, INC. | Process Industries |
| Private Unternehmen | 4 |
|---|---|
General Communication, Inc.
General Communication, Inc. Specialty TelecommunicationsCommunications General Communication, Inc. is a holding company. It provides wireless telephone services, data services, Internet access, video services and local and long-distance voice services, to residential and business customers across the state under its GCI brand. It operates through the Wireless and Wireline segments. The Wireless segment provides wholesale wireless services to wireless carriers. The Wireline segment offers services and products to the following three major customer groups: Consumer, Business Services and Managed Broadband. The company was founded by Robert M. Walp and Ronald A. Duncan in 1979 and is headquartered in Anchorage, AK. | Communications |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA. | Health Technology |
| Europolitan Holdings AB | Communications |
